Physician profile
Harsh Sachdeva
NPI 1205944493
$13,459.15
in general payments reported to CMS, 2019-2025
31 companies · $2,696 in 2025
The $2,696 reported for 2025 was more than what 87% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,276 · 2020: $1,076 · 2021: $1,944 · 2022: $948 · 2023: $2,603 · 2024: $2,916 · 2025: $2,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,085 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,084.61 |
| Education | $131.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,986.24 | 2019-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter, General - Therapies |
| Medtronic, INC. | $1,759.12 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Vertos Medical, INC. | $1,573.46 | 2020-2024 | Mild Device Kit |
| Abbott Laboratories | $1,196.09 | 2019-2025 | Proclaim, Eterna |
| Stryker Corporation | $484.42 | 2023-2024 | Mild Device Kit, Omnicurve, Multigen 2 |
| Abbvie INC. | $451.06 | 2021-2025 | Qulipta, Ubrelvy |
| Medtronic USA, INC. | $368.76 | 2019-2020 | |
| Saluda Medical Americas, INC. | $366.45 | 2024-2025 | Evoke |
| Amgen INC. | $336.24 | 2019-2020 | |
| Nevro Corp. | $308.32 | 2019-2021 | |
| Avanos Medical | $267.93 | 2021-2025 | Standard Rf Disposables |
| Curonix LLC | $219.55 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $210.70 | 2023-2025 | Qutenza |
| Biotronik Nro, INC. | $158.90 | 2025 | Prospera |
| Nalu Medical, INC. | $143.07 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $118.74 | 2021-2022 | |
| Tersera Therapeutics LLC | $116.10 | 2025 | Prialt |
| Vertex Pharmaceuticals Incorporated | $52.87 | 2024-2025 | |
| Vertiflex, INC. | $44.18 | 2019 | |
| Pfizer INC. | $40.94 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $37.73 | 2021 | |
| Mml US, INC. | $37.45 | 2025 | Reactiv8 |
| Stimwave Technologies Incorporated | $33.00 | 2021 | |
| Spinefrontier, INC. | $27.24 | 2020 | |
| Globus Medical, INC. | $23.97 | 2025 | Senza |
| Spr Therapeutics, INC | $20.38 | 2025 | Sprint Pns System |
| Bioventus LLC | $18.23 | 2024 | Durolane |
| Allergan, INC. | $16.00 | 2020 | |
| Azurity Pharmaceuticals, INC. | $15.95 | 2023 | Horizant |
| Scilex Pharmaceuticals INC. | $13.98 | 2024 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harsh Sachdeva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.